The series C round featured Alphabet and Celgene, and will help Armo advance therapies for patients who have not responded to current immuno-oncology treatments.

EpiBiome, a past winner of Johnson & Johnson's JLabs QuickFire Challenge, has raised $6m in an Alexandria Real Estate Equities-backed round

Biogen and Sanofi are among the investors in a series A round closed by Yumanity Therapeutics, which plans to now advance its neurological disease treatment platforms.

The Washington University spinout raises capital to develop a therapy for pancreatic cancer.

Enterprise software supplier Kainos joined Queen's University Belfast's TTO for medical diagnostics company Cirdan's latest round.

The Quest Award will involve entrepreneurs competing for the chance to develop technology that can help combat cervical cancer.

University of Maryland, Baltimore hopes to treat cancer by inking a deal with Immunocellular Therapeutics to support three T-cell therapy-related projects.

The pharmaceutical group will invest in oncology and dermatology companies, startups and laboratories through the Pierre Fabre Fund for Innovation.

Enterprise software supplier Kainos joined Bank of Ireland-backed Kernel Capital for medical diagnostics company Cirdan's latest round.